CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the changes to F...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...